The population-level effects of omitting chemotherapy guided by a 21-gene expression assay in node-positive breast cancer: a simulation modeling study

KM Wojcik, JL Caswell-Jin, OWA Wilson, C Schechter… - BMC cancer, 2024 - Springer
Background A recent trial showed that postmenopausal women diagnosed with hormone
receptor-positive, human epidermal growth factor receptor-2 (HER2)-negative, lymph node …

The budget impact of utilizing the Oncotype DX Breast Recurrence Score test from a US healthcare payer perspective

V Berdunov, E Laws, G Cuyun Carter… - Journal of Medical …, 2023 - Taylor & Francis
Abstract Background and objectives The Oncotype DX Breast Recurrence Score test is used
to estimate distant recurrence risk of hormone receptor-positive (HR+) and human epidermal …